Pressmeddelanden, rapporter och bolagsmeddelande för Dancann Pharma

Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Dancann Pharma

Press release from Companies: DanCann Pharma A/S: Tetra Bio-Pharma Receives Positive Opinion for Orphan Drug Designation for QIXLEEF™ from the European Medicines Agency
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Dancann Pharma

Press release from Companies: DanCann Pharma A/S: Correction: Flagging announcement in DanCann Pharma A/S
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Dancann Pharma

Press release from Companies: Flagging announcement in DanCann Pharma A/S
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Dancann Pharma

Press release from Companies: DanCann Pharma A/S Announces Closing of the Previously Announced Acquisition of CannGros ApS
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Dancann Pharma

Press release from Companies: DanCann Pharma A/S: Medicinal cannabis bill is an important step in the right direction
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Dancann Pharma

Press release from Companies: Correction: DanCann Pharma A/S acquires CannGros ApS and becomes market leader in the Danish market under the Pilot Programme with Medical Cannabis
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Dancann Pharma

Press release from Companies: DanCann Pharma A/S successfully completes a directed issue of units of approx. 8 MDKK
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Dancann Pharma

Press release from Companies: DanCann Pharma A/S announces its intention to carry out a directed issue of units
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Dancann Pharma

Press release from Companies: DanCann Pharma A/S acquires CannGros ApS and becomes market leader in the Danish market under the Pilot Programme with Medical Cannabis
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Dancann Pharma

Press release from Companies: DanCann Pharma A/S informs about the outcome of the TO1